METANALYSIS OF CALCITONIN IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS (PMO)

被引：0
|
作者：
CRANNEY, A
MOHER, D
SHEA, B
WELLS, G
ADACHI, R
TUGWELL, P
机构：
[1] UNIV OTTAWA,OTTAWA,ON K1N 6N5,CANADA
[2] OTTAWA GEN HOSP,OTTAWA,ON K1H 8L6,CANADA
[3] MCMASTER UNIV,HAMILTON,ON,CANADA
来源：
ARTHRITIS AND RHEUMATISM | 1995年 / 38卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1240 / 1240
页数：1
相关论文
共 50 条
  • [31] Comparison of the effects of teriparatide and calcitonin in the treatment of postmenopausal Chinese women with osteoporosis
    Blair, J. M.
    Dai, K. R.
    Chen, D. C.
    Zhang, Z. L.
    Zhang, K. Q.
    Wang, B. Q.
    He, L.
    Liu, B.
    Xu, H. Z.
    Hu, Y. L.
    Cao, Y. P.
    Thiebaud, D.
    Yu, M.
    Luo, T. H.
    BONE, 2009, 44 : S74 - S74
  • [32] Alendronate Vs intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
    Downs, RW
    Favus, M
    Walsh, B
    Bell, NH
    Ettinger, MP
    Wang, L
    Mako, B
    Smith, ME
    Gormley, GJ
    Melton, ME
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S401 - S401
  • [33] TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH CALCITONIN AND CALCIUM - LONG-TERM RESULTS
    LENZA, HR
    DIEZ, ERH
    NUNEZTORRON, M
    ARANGUREN, JT
    PEREZ, DE
    MEDICINA CLINICA, 1985, 84 (14): : 563 - 565
  • [34] Treatment of osteoporosis in postmenopausal women: Alendronate vs intranasal calcitonin.
    Schnitzer, TJ
    Rosen, CJ
    Bonnick, SL
    Miller, PD
    McClung, MR
    Wasnich, RD
    Weiss, SR
    Woodson, GC
    Lenihan, JP
    Ross, RP
    Wang, L
    Smith, ME
    Gormley, GJ
    Melton, ME
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S177 - S177
  • [35] Treatment of osteoporosis in postmenopausal women: Alendronate Vs intranasal calcitonin.
    Rosen, CJ
    Bonnick, SL
    Miller, PD
    McClung, M
    Wasnich, RD
    Weiss, SR
    Woodson, GC
    Schnitzer, TJ
    Lenihan, JP
    Ross, RP
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S400 - S400
  • [36] BGP (OSTEOCALCIN) VALUES IN POSTMENOPAUSAL OSTEOPOROSIS BEFORE AND AFTER TREATMENT WITH CALCITONIN
    RICO, H
    CABRANES, JA
    NUNEZTORRON, M
    HIGUERAS, JC
    HERNANDEZ, ER
    MEDICINA CLINICA, 1986, 86 (19): : 791 - 793
  • [37] CALCITONIN TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - EVALUATION OF EFFICACY BY PRINCIPAL COMPONENTS ANALYSIS
    MILHAUD, G
    TALBOT, JN
    COUTRIS, G
    BIOMEDICINE, 1975, 22 (03): : 223 - 232
  • [38] Treatment of osteoporosis in postmenopausal women: Alendronate vs intranasal calcitonin.
    Rosen, CJ
    Bonnick, SL
    Miller, PD
    McClune, M
    Wasnich, RD
    Weiss, SR
    Woodson, GC
    Schnitzer, TJ
    Lenihan, JP
    Ross, RP
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S399 - S399
  • [39] Bisphosphonate (BP) Treatment and Renal Impairment (RI) in Women with Postmenopausal Osteoporosis (PMO) in UK
    Xue, Fei
    Wentworth, Charles
    Petraro, Paul
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 271 - 272
  • [40] Economic analysis:: Ibandronate (Bonviva®) IV injection for the treatment of postmenopausal osteoporosis (PMO) in the UK
    Cowell, W.
    Koay, A.
    Hunjan, M.
    VALUE IN HEALTH, 2006, 9 (06) : A380 - A380
12345